The acridine derivative tacrine was the first AChE inhibitor developed to improve the cognitive performance of Alzheimer’s disease (Raina et al., 2008), and ranitidine is an inhibitor of histamine type 2 (H2) receptors, which is widely used to reduce gastric acid production (Grant et al., 1989). Here, ACHE is linked to Alzheimer disease.